Read + Share
Amedeo Smart
Independent Medical Education
Miele E, Abballe L, Spinelli GP, Besharat ZM, et al. BRAF mutant colorectal cancer: ErbB2 expression levels as predictive factor for the response to combined BRAF/ErbB inhibitors. BMC Cancer 2020;20:129.PMID: 32066410
Email
LinkedIn
Facebook
Twitter
Privacy Policy